WHO PABS Negotiations: Progress on Pandemic Agreement Annex

Berlin – Global health security took a significant step forward this month as representatives from member states of the World Health Organization (WHO) concluded a week of intensive negotiations focused on a crucial annex to the landmark WHO Pandemic Agreement. The discussions, centering on the Pathogen Access and Benefit-Sharing (PABS) system, took place from February 9th to 14th, 2026, and signal a continued commitment to strengthening international collaboration in the face of future pandemic threats. This PABS system is designed to ensure equitable access to the tools needed to combat outbreaks, a lesson painfully learned during the COVID-19 pandemic.

The COVID-19 pandemic exposed critical vulnerabilities in global health systems, particularly regarding the rapid development and equitable distribution of vaccines, diagnostics, and treatments. The resulting inequities not only led to preventable loss of life, especially in lower-income countries, but also prolonged the pandemic by allowing new variants to emerge and spread. The WHO Pandemic Agreement, adopted in May 2025, represents a historic effort to address these shortcomings and build a more resilient global health architecture. The current negotiations surrounding the PABS annex are vital to realizing the agreement’s full potential.

The Pathogen Access and Benefit-Sharing System: A Cornerstone of Pandemic Preparedness

At the heart of the PABS system lies the principle of rapid and transparent sharing of pathogen materials and genetic sequence data. Scientists agree that quickly identifying pathogens with pandemic potential and making that information widely available is essential for accelerating the development of effective countermeasures. This includes diagnostic tests, treatments, and, crucially, vaccines. The PABS system aims to facilitate this sharing on an equitable footing, ensuring that benefits derived from these resources are also shared fairly, particularly with countries that may lack the resources to conduct their own research and development. The Coalition for Epidemic Preparedness Innovations (CEPI) highlights the importance of strengthening pandemic prevention and surveillance capacities as a key component of the agreement.

The negotiations this month focused on streamlining the text of the annex while addressing more contentious elements through continued consultation. Ambassador Tovar da Silva Nunes of Brazil, co-chair of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement, emphasized the steadfast commitment of countries to finalizing the PABS annex. “We now have a clear vision for streamlining the text, while ensuring that the more contentious elements receive the necessary consultation,” she stated. Mr. Matthew Harpur of the United Kingdom, the other IGWG Bureau co-chair, acknowledged that important differences remain but underscored a shared recognition of the stakes involved. “With time running short, the coming weeks will be critical in bridging the remaining gaps and delivering a Pathogen Access and Benefit Sharing annex that is fair, effective, and fit for purpose,” he added.

Addressing Key Challenges in Pathogen Sharing

While the principle of sharing pathogen data seems straightforward, several complex challenges have emerged during the negotiations. These include concerns about intellectual property rights, benefit-sharing mechanisms, and ensuring that the system is implemented in a way that respects national sovereignty. The WHO Pandemic Agreement explicitly affirms national sovereignty in public health matters, and does not grant the WHO authority to dictate national policies. As CEPI explains, the agreement focuses on collaboration, not control.

One key area of discussion revolves around the concept of “benefits.” These benefits extend beyond simply access to vaccines and treatments and can include technology transfer, capacity building, and financial resources. Finding a formula for equitable benefit-sharing that satisfies all member states is proving to be a delicate balancing act. The goal is to incentivize countries to share pathogen data while ensuring that those who contribute to the global effort also receive tangible benefits in return. Stakeholders from the private sector, academia, laboratories, and sequence information databases were engaged in dialogues alongside the negotiations, reflecting the broad range of interests involved.

The Road Ahead: May Deadline and Beyond

Member states are scheduled to resume negotiations next month, with a target deadline of May 2026 to present the final PABS annex to the World Health Assembly (WHA). The WHA, the decision-making body of the WHO, will then have the opportunity to adopt the annex, bringing it one step closer to becoming a legally binding international instrument. Once adopted, the annex will be open for signature and ratification by individual countries, with the agreement entering into force 30 days after 60 countries have ratified it. According to the WHO, the entire process, from the initial launch in 2021 to full implementation, represents three years of intensive work.

WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized the importance of building on the momentum generated by the adoption of the Pandemic Agreement last year. “Strong multilateralism remains essential as countries have to face future pandemics together, collectively,” he stated. He expressed confidence that member states will reach an agreement on the PABS annex in time for the May WHA meeting, recognizing the steady progress being made. The successful implementation of the PABS system, and the broader WHO Pandemic Agreement, will require sustained political will, financial investment, and a commitment to global solidarity.

What Does This Mean for Global Health Security?

The ongoing negotiations and the eventual implementation of the PABS system represent a paradigm shift in how the world approaches pandemic preparedness and response. By fostering greater transparency and collaboration in the sharing of pathogen data and benefits, the agreement aims to reduce the risk of future pandemics and mitigate their impact when they do occur. This is not simply a matter of scientific advancement; it is also a matter of equity and social justice. Ensuring that all countries have access to the tools they demand to protect their populations is essential for building a more resilient and equitable global health system.

The agreement also underscores the importance of a “One Health” approach, recognizing the interconnectedness of human, animal, and environmental health. CEPI notes that the agreement aims to watch for potential drivers of pandemics at the human-animal-environment interface, strengthening early warning systems and improving routine immunization programs. This holistic approach is crucial for preventing future outbreaks and protecting global health security.

The next crucial step is the May meeting of the World Health Assembly, where member states will review the finalized PABS annex. Following that, the focus will shift to national ratification processes, paving the way for the agreement to enter into force. The world will be watching closely as this landmark agreement moves closer to becoming a reality, offering a beacon of hope in the ongoing fight against infectious diseases.

What are your thoughts on the WHO Pandemic Agreement and the PABS system? Share your comments below, and let’s continue the conversation about building a more resilient and equitable global health future.